Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study
mediaposted on 10.06.2021, 10:16 by Adis journals on behalf of, Abdullah M. Alguwaihes
Article full text
The above summary slide represents the opinions of the author. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The author, CC-BY-NC 2021.